Fortress Biotech

Fortress Biotech is a company listed under the stock ticker FBIO (US).

Fortress Biotech has 4 subsidiaries including Avenue Therapeutics, Checkpoint Therapeutics and Journey Medical Corp.

They are in:

• Biotechnology80%
• Pharmaceuticals20%

View the org chart displaying its 58 main executives

Most searched biographies at Fortress Biotech

• Lindsay Rosenwald, Chairman, President, and Chief Executive Officer
• Jay Lobell, Director
• Kevin Lorenz, Director

Create your alert
to follow the executive moves at Fortress Biotech.

Fortress Biotech has 2,276 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Bruker has announced the acquisition of NanoString Technologies  (posted on April 18 2024).
• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).
• Nurix Therapeutics has just announced a $175 Million fundraising (posted on April 13 2024).

Popular contacts in Biotechnology

• Vik Bajaj - Director at Interline Therapeutics
• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Fortress Biotech

• Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
• Press Releases
• Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases
• Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease
• Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade Glioma
• Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy
• Checkpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-Market
• Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference
• Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference
• Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference
• View more press releases Close

Social media about Fortress Biotech

• Fortress Biotech on Wikipedia, Google News & Yahoo Finance
• Fortress Biotech on LinkedIn, Twitter & YouTube

Contact by email its executives including Lindsay Rosenwald

Call Fortress Biotech at +1 781...

View the org chart

Register to receive your alert

Report an error